Boston Scientific Corp (BSX)

Industry Medical Devices

This stock can be held in an Investment ISA and an Investment Account

Sell

$92.00

Buy

$92.97

arrow-up$0.83 (+0.90%)

Prices updated at 13 Dec 2025, 00:56 EST

Prices minimum 15 mins delay

Prices in USD

Boston Scientific Corp is a developer, manufacturer, and marketer of medical devices. The firm markets its devices to health-care professionals and institutions globally. Foreign sales account for nearly half of the firm's total sales.

S&P 500

-1.07%

NYSE

Important documents: Please ensure that you have read the Pre-sale Illustrations document & Doing Business with Fidelity document (incorporating the Fidelity Client Terms) and

Our Investment Fees and Charges.

Income statement

Year chevron-l-regular chevron-r-regular	2023	2024
	14,240m	16,747m
	9,896m	11,490m
	2,418m	3,002m
	16.98	17.93
	1,593m	1,854m
	3,446m	3,856m
Sales, General and administrative	5,190m	5,984m
Interest expenses	265m	305m
Provision for income taxes	393m	436m
Operating expenses	7,478m	8,488m
Income before taxes	1,985m	2,282m
Net income available to common shareholders	1,570m	1,853m
	1.08	1.26
Net interest income	-243m	-198m
Advertising and promotion	-	-
Net investment income, net	-	-
Realised capital gains (losses), net	-	-
Total benefits, claims and expenses	-	-
Earnings per share (diluted)	1.07	1.25
Free cash flow per share	1.1265	1.2762
Book value/share	12.8845	14.0435
Debt equity ratio	0.464758	0.430363

Balance sheet

Year chevron-l-regular chevron-r-regular	2023	2024
Current assets	6,514m	6,920m
Current liabilities	4,933m	6,399m
Total capital	27,847m	30,612m
Total debt	9,492m	11,147m
Total equity	19,281m	21,770m
Total non current liabilities	-	-
Loans	8,566m	8,842m
Total assets	35,136m	39,395m
Total liabilities	-	-
Cash and cash equivalents	865m	414m
Common stock	1,466m	1,475m

Cash flow

Year chevron-l-regular chevron-r-regular	2023	2024
Cash at beginning of period	1,126m	1,055m
Cash dividends paid	-28m	-
	1,703m	2,365m
Investments (gains) losses	-2,574m	-5,687m
	1,055m	606m
Net income	-	-
	2,503m	3,435m
	-800m	-1,070m

The figures shown in the tables are quoted in the currency of the stock selected.

Please note that past performance is not a reliable indicator of future returns. Please use the interactive graph for benchmark comparison.

Important Information

Investment values, and income from investments, can go down as well as up, so you may get back less than you invest. This is not a personal recommendation for a specific investment. If you're not sure which investments are suitable for you, consult Fidelity's advisers or another authorised financial adviser. The information contained herein: is proprietary to Morningstar and/or its content providers; may not be copied or distributed; and is not warranted to be accurate, complete or timely. Neither Morningstar nor its content providers are responsible for any damages or losses arising from any use of this information.